Workflow
换血抗衰
icon
Search documents
提取年轻人血液、换血治疗?被海尔打假的医美老板有多野
凤凰网财经· 2026-03-30 13:15
Core Viewpoint - The article discusses the controversies surrounding Yu Wenhong, the chairman of Yumeiren Group, and her dubious business practices, particularly the promotion of unscientific anti-aging treatments like "blood transfusion therapy" and "eternal needles" [1][5][12]. Group 1: Company Background and Expansion - Yu Wenhong started her career in the beauty industry by opening a small beauty workshop in Dalian in 1992, which later evolved into the Yumeiren brand [7]. - By 2005, Yumeiren had over 150 franchise stores nationwide, and by 2011, it began international collaborations, establishing anti-aging centers in multiple countries [9]. - Currently, Yu Wenhong is associated with 47 companies, with 21 of them already deregistered or revoked, while Yumeiren continues to operate 30 clinics across major cities in China [14]. Group 2: Controversial Practices and Legal Issues - Yu Wenhong has faced numerous controversies, including accusations of practicing medicine without a license and misleading marketing claims about her anti-aging treatments [18][20]. - In 2022, she was implicated in a tax evasion case, where it was revealed that her company concealed over 47.55 billion yuan in income, leading to significant fines [22]. - The company has also faced regulatory penalties for advertising violations, including a fine of 2 million yuan in 2023 for illegal medical advertising [23]. Group 3: Marketing Tactics and Scientific Validity - Yu Wenhong's marketing strategies include promoting "blood transfusion therapy" as a revolutionary anti-aging treatment, which lacks scientific backing and poses health risks [12][14]. - The concept of "blood transfusion therapy" is based on flawed animal studies and has been discredited by health authorities, including the FDA, which warned against its use for non-medical purposes [16][17]. - Despite the lack of evidence supporting her claims, Yu Wenhong continues to market these treatments at exorbitant prices, claiming they are exclusive to wealthy clientele [12][13]. Group 4: Ongoing Controversies and Industry Implications - The ongoing disputes within Yu Wenhong's family and her public persona as a self-made entrepreneur contrast sharply with the legal and ethical challenges she faces [22][24]. - The article highlights the broader implications of her practices for the medical aesthetics industry, reflecting concerns about compliance and the potential for exploitation of consumers [25].